Agilent Technologies and Sage Science Sign Agreement to Comarket Bioanalyzer and Pippin Prep DNA Systems

WALDBRONN, Germany, and BEVERLY, Mass., Feb. 1, 2011 — Agilent Technologies Inc. (NYSE: A) and Sage Science Inc. today announced that they have signed a comarketing agreement involving Agilent’s 2100 Bioanalyzer, used for the detection and quantification of nucleic acids, and Sage’s Pippin Prep DNA size-selection system.

The agreement between Sage and Agilent includes the copromotion of the respective products and development of application studies that will leverage the synergies of the two systems for next-generation sequencing applications.

“We are very pleased to be working with Agilent; our companies’ products are clearly complementary for the size-selection steps in next-generation sequencing,” said Gary Magnant, Sage CEO. “The high sensitivity of the 2100 Bioanalyzer kits provides superb analysis of DNA size distributions, with minimal sample consumption.”

Proper preparation and quality control of the input sample, as well as the library, are essential to achieving high-fidelity data in the next-generation sequencing workflow. The Pippin Prep, which automates DNA size selection for creating libraries, together with Agilent’s 2100 Bioanalyzer, the market-leading tool for sample and library quality control, advances and streamlines sample preparation.

“The Pippin Prep instrument from Sage and Agilent’s Bioanalyzer together offer a synergistic set of tools that enable researchers working with next-generation sequencing platforms to advance their research faster and more efficiently,” said Knut Wintergerst, electrophoresis marketing and support manager, Agilent.

This entry was posted in Press Release and tagged . Bookmark the permalink.

Comments are closed.